Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar.N Engl J Med. 2022 03 17; 386(11):1091-1093.NEJM
Links
MeSH
Pub Type(s)
Letter
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
35081294
Citation
Abu-Raddad, Laith J., et al. "Waning mRNA-1273 Vaccine Effectiveness Against SARS-CoV-2 Infection in Qatar." The New England Journal of Medicine, vol. 386, no. 11, 2022, pp. 1091-1093.
Abu-Raddad LJ, Chemaitelly H, Bertollini R, et al. Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar. N Engl J Med. 2022;386(11):1091-1093.
Abu-Raddad, L. J., Chemaitelly, H., & Bertollini, R. (2022). Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar. The New England Journal of Medicine, 386(11), 1091-1093. https://doi.org/10.1056/NEJMc2119432
Abu-Raddad LJ, et al. Waning mRNA-1273 Vaccine Effectiveness Against SARS-CoV-2 Infection in Qatar. N Engl J Med. 2022 03 17;386(11):1091-1093. PubMed PMID: 35081294.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar.
AU - Abu-Raddad,Laith J,
AU - Chemaitelly,Hiam,
AU - Bertollini,Roberto,
AU - ,,
Y1 - 2022/01/26/
PY - 2022/1/27/pubmed
PY - 2022/3/23/medline
PY - 2022/1/26/entrez
SP - 1091
EP - 1093
JF - The New England journal of medicine
JO - N Engl J Med
VL - 386
IS - 11
SN - 1533-4406
UR - https://www.unboundmedicine.com/medline/citation/35081294/Waning_mRNA_1273_Vaccine_Effectiveness_against_SARS_CoV_2_Infection_in_Qatar_
DB - PRIME
DP - Unbound Medicine
ER -